Katie Arcieri

Arlington, Washington, D.C.

Senior Antitrust Litigation Reporter at Bloomberg Industry Group

I cover antitrust litigation for Bloomberg Industry Group.

Articles

Justices Approve New Multidistrict Litigation Management Rule

1 day ago | news.bloomberglaw.com | Jacqueline Thomsen |Katie Arcieri

The US Supreme Court has adopted a new federal rule on how courts handle initial steps in multidistrict litigation, teeing it up to go into effect later this year. The court on Wednesday transmitted to Congress the multidistrict litigation rule, among other changes to the federal rules of civil, appellate, and bankruptcy procedure. Unless Congress takes action, those rule changes will go into effect on Dec. 1.
AstraZeneca Subsidiary Accused of Soliris Drug Market Monopoly

1 week ago | news.bloombergtax.com | Katie Arcieri

A unit of AstraZeneca Plc is facing a new antitrust suit claiming the company monopolized the market for a blood disorder drug by blocking competitors that wanted to launch similar, less-expensive versions of the medication. Alexion Pharmaceuticals Inc. forced buyers to pay higher prices for brand-name Soliris by delaying the entry of generics at far lower prices, health insurer EmblemHealth Inc.
AstraZeneca Subsidiary Accused of Soliris Drug Market Monopoly

1 week ago | news.bloomberglaw.com | Katie Arcieri

A unit of AstraZeneca Plc is facing a new antitrust suit claiming the company monopolized the market for a blood disorder drug by blocking competitors that wanted to launch similar, less-expensive versions of the medication. Alexion Pharmaceuticals Inc. forced buyers to pay higher prices for brand-name Soliris by delaying the entry of generics at far lower prices, health insurer EmblemHealth Inc.
Live Nation, Ticketmaster Fail to Escape Consumer Antitrust Suit

1 week ago | news.bloomberglaw.com | Katie Arcieri

Live Nation Entertainment Inc. and its Ticketmaster LLC unit must face consumer plaintiffs’ antitrust claims that they conspired to monopolize the ticketing services industry, after a judge mostly denied the companies’ motion to dismiss. Judge George H. Wu of the US District Court for the Central District of California in an April 11 ruling held that the consumer plaintiffs cleared a threshold issue in antitrust cases by adequately arguing that Live Nation had market power.
Live Nation, Ticketmaster Fail to Escape Consumer Antitrust Suit

1 week ago | news.bloombergtax.com | Katie Arcieri

XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.
US Soccer, Relevent Sports Reach Settlement in FIFA Match Case

2 weeks ago | news.bloomberglaw.com | Katie Arcieri

Soccer promoter Relevent Sports LLC and US Soccer reached an undisclosed deal to settle an antitrust case challenging a FIFA policy that banned foreign teams from playing official matches on US soil. Relevent Sports voluntarily dismissed the case against US Soccer on Wednesday in the US District Court for the Southern District of New York. “We appreciate U.S. Soccer’s collaboration in reaching this settlement,” said Relevent CEO Danny Sillman in a statement.
FTC Defeats Amazon Bid to Block Antitrust Suit in Federal Court

2 weeks ago | news.bloomberglaw.com | Katie Arcieri

The Federal Trade Commission has the authority to pursue its suit in federal court accusing Amazon.com Inc. of running an online marketplace monopoly, a judge ruled. Judge John H. Chun of the US District Court for the Western District of Washington on April 8 denied Amazon’s motion to enter judgment on the agency’s claims that the company improperly stifled competition.
FTC Defeats Amazon Bid to Block Antitrust Suit in Federal Court

2 weeks ago | news.bloombergtax.com | Katie Arcieri

XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.
Bristol Myers Freed From Blood Cancer Drug Antitrust Litigation

2 weeks ago | news.bloombergtax.com | Katie Arcieri

Bristol-Myers Squibb Co. got dismissal of a lawsuit alleging the company used reverse-payment agreements to delay the generic version of blood cancer drug Pomalyst, after a federal judge ruled the plaintiffs failed to state a claim.
Gaming Products Firm Dismissed From Card Shuffler Antitrust Case

2 weeks ago | news.bloombergtax.com | Katie Arcieri

XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.